< PreviousHEALTH, SAFETY AND HYGIENE 30 Pharma Business International www.pbiforum.net © stock.adobe.com/RGtimeline 28-31.qxp_Layout 1 10/02/2023 14:28 Page 3Pharma Business International 31 www.pbiforum.net HEALTH, SAFETY AND HYGIENE accountable for the PPE’s quality. Ultimately, more people in the chain of PPE are being held responsible for the equipment doing what it should, not just the creator and user. If one is a manufacturer or distributor of PPE one must become more stringent in checking PPE. PPE protecting from high-risk incidents now have a more rigid compliance procedure, and a declaration of conformity must be provided with the equipment, or online, as evidence that it meets regulation. This documentation must be held by the supplier for at least 10 years once it is up for sale. Instructions must be also provided, labelling requirements met, the manufacturer’s name and address must feature on the product, and sample tests must be conducted. All of these regulations are in place to make sure the equipment is of a high enough standard for users, benefitting businesses and employees, as one can be more confident that the PPE is fit for its purpose, and will be effective at preventing injury. It is important to know these changes even if you are not the manufacturer or distributer as employers need to be able to identify that their PPE meets regulation. In addition, it is important to mention that the new PPE regulation makes changes to how certain pieces of equipment are classified in their risk categorisation, so that they are considered a product protecting from a serious injury or contamination of medical products. Ultimately, we live in a time where hygiene is more important than ever, and the last thing anyone needs is a factory locked down due to a scare. resort to protect employees from workplace hazards. Regulation notes that equipment must be provided free to workers and chosen carefully in accordance with what is needed. To do this, as an employer providing PPE, you also have the responsibility of checking with your supplier what attire is appropriate, whether it be safety gloves, outfits or cleaning supplies. When choosing PPE products, one should consider the hazards in that particular workplace. The HSE also advises having the employee using the equipment help choose it so they are more likely to wear it and so it is a suitable size, fit, and weight. Though it may seem obvious, employers and employees, including managers not likely to use it, in accordance with regulation must be trained how to use their equipment and know why and where to use it. Employers have a responsibility to make sure staff are using PPE correctly or could face legal trouble in the event of an accident. It is also the responsibility of the PPE provider to make sure you are taught how to use the equipment. A useful piece of advice is using safety signs to remind staff where PPE should be used. Further, employers are considered responsible for making sure PPE is stored and maintained correctly. Regulation changes in recent years have drastically impacted PPE. The latest regulation does not particularly affect the staff using PPE, rather the duties of the equipment’s suppliers, distributors and producers, to include those previously unaffected by regulation, such as importers who are now being held 28-31.qxp_Layout 1 10/02/2023 14:28 Page 4Cloud Computing for Drug Development Congress 22 - 23 February San Diego, USA In today’s economy, it’s never been more important to elevate a data-driven culture. Cloud computing has opened doors that make this goal a real possibility. Biopharma, however, faces a multitude of big data challenges: the high cost of data ops; exponential growth of data filled with inconsistencies, and potential biases; and dependencies on centralized capabilities. The Cloud Computing for Drug Development Congress enables you to tackle these issues head-on. Connect in person with pioneers of this field who are driving the optimization of cloud strategies across their organizations and equip yourself with the tools needed to develop an interoperable data & analytics ecosystem. DigiPharma Connect 2023 26 - 28 February Austin, USA DigiPharma Connect is an exclusive, peer to peer event for senior digital marketing executives from top pharma and biotech companies to come together to network, meet with relevant solution providers and discuss cutting-edge trends in the industry. Every attendee controls their company’s buying power and budget and is looking to invest – so everyone you will meet is a decision maker. Pharma EVENTS © stock.adobe.com/ SweetBunFactory 32 Pharma Business International www.pbiforum.net Women’s Health Innovation Summit Europe 26 - 27 April Basel, Switzerland The Women’s Health Innovation Summit Europe is returning to Switzerland to drive its mission of improving the access to and 7th Commercializing Continuous Processing in Pharma Summit 7 - 9 March Boston, USA Hosting leading companies and minds in the space, explore the end-to-end integration of continuous manufacturing in pharma, alongside 120+ senior attendees from process development and engineering, manufacturing, CMC, regulatory affairs, QA/QC and MS&T. 4th Glioblastoma Drug Development Summit 14 - 16 March Boston, USA Glioblastoma continues to be one of the most devastating diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for. Returning as an in-person meeting after three years, leading experts in the field, from key decision makers in pharma and biotech to academic pioneers will re-unite at the 4th Glioblastoma Drug Development Summit to celebrate successes, learn from failures and explore novel approaches in GBM drug development over the past 12 months. © stock.adobe.com/Scanrail AI in Drug Discovery 13 - 14 March London, UK With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through the use of machine and deep learning. The current challenges within the drug discovery industry include the significant time consumption and expenses involved. This conference will discuss the solutions to these problems with presentations and updates from leading industry experts. 32-33.qxp_Layout 1 10/02/2023 14:29 Page 1quality of healthcare for women across the globe. Whilst the distribution of FemTech companies in Europe currently sits at 27% (in comparison to North America’s 51%), there is the potential for huge growth in the market. This event aims to act as the catalyst for this growth in the development of solutions in this underserved area. The summit will offer the opportunity for connection and partnership, bringing together the leaders and innovators from Europe and Israel, from large pharmaceutical companies and biotechs to start- ups, investors, and service providers, to collectively drive forward the women’s health market. CHEMUK 2023 10 - 11 May Birmingham, UK CHEMUK is now established as the UK’s annual Chemical, Laboratory & Process Industries Supply Chain Expo & Speaker Programme. The Expo comprises three shows; ‘The Chemical Industries Supply Chain Show’, ‘The Chemical, Process & Plant Engineering Show’, and, new for 2023, ‘The CHEMLAB Show’. The CHEMUK two-day speaker programme will host some 150+ expert speakers discussing the big challenges and opportunities affecting the UK’s chemical & chemical product industries. www.pbiforum.net Pharma Business International 33 © stock.adobe.com/DC Studio Pharma Contract Manufacturing 28 - 30 March Berlin, Germany In this time of fast-moving shifts within the industry, increasing supply chain pressures and enhanced global demand for services, the pharma industry is continually looking to leverage external partnerships and engagements. With supply chain issues abound, increasing costs and lead-times, coupled with the energy crisis, alongside ever- changing regulatory changes, it is a necessity for manufacturers to determine where they outsource to, and whom best to partner with. Against this backdrop and incorporating the current global environment - Pharma Contract Manufacturing offers a detailed, informative, and highly interactive three-day program that will exhibit a variety of case-studies to provide the industry with opportunities to learn from each other’s experience and find solutions to their current challenges. Pharmaceutical Microbiology USA 26 - 27 April Boston, USA Join leading experts in 2023 to discuss and analyse the latest advances and challenges surrounding Pharmaceutical Microbiology. Network with industry professionals, discuss revisions in regulatory and guidance documents, and gain a deeper insight into this corner of the field. 32-33.qxp_Layout 1 10/02/2023 14:29 Page 2FEATURES Transport and Logistics Labelling, Coding and Marking End of Line Packaging Clinical Trials Waste Management Next issue: Deadline - 29th March 2023 REGULARS News Events M&A Round-up Eye On Approvals Visit us at www.pbiforum.net where you’ll find the latest news as it breaks – and why not subscribe to our newsletters so you can have the latest news emailed to your inbox, in between digital issues? @pbiforumwww.pbiforum.netcompany/pbiforum 34.qxp_Layout 1 10/02/2023 14:29 Page 1Next >